GlassScriptPhysician profile
James O Miller
NPI 1225042740
$2,048.90
in general payments reported to CMS, 2019-2025
28 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $260 · 2021: $394 · 2022: $441 · 2023: $295 · 2024: $227 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.66 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $588.21 | 2019-2023 | |
| Astellas Pharma US INC | $199.73 | 2022-2025 | Veozah |
| Avion Pharmaceuticals | $178.17 | 2020-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $100.56 | 2021-2023 | |
| Millicent US INC | $91.15 | 2021-2025 | Intrarosa, Femring, Femlyv |
| Mylan Pharmaceuticals INC. | $73.38 | 2020-2022 | |
| Shield Therapeutics INC | $72.77 | 2023-2024 | Accrufer |
| Sumitomo Pharma America, INC. | $72.06 | 2024 | Myfembree |
| Lupin INC. | $65.79 | 2019 | |
| Daiichi Sankyo INC. | $59.65 | 2019-2021 | |
| Allergan, INC. | $48.94 | 2019-2020 | |
| Coloplast Corp | $47.03 | 2025 | |
| Pfizer INC. | $46.43 | 2020-2024 | |
| Duchesnay USA Incorporated | $42.15 | 2019 | |
| Organon LLC | $40.33 | 2023-2025 | Nexplanon |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $38.39 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.19 | 2025 | |
| Myovant Sciences INC. | $35.16 | 2021 | |
| Olympus America INC. | $34.68 | 2023 | Olympus |
| Vertical Pharmaceuticals, LLC | $34.07 | 2019 | |
| Exeltis, USA INC. | $29.12 | 2023-2025 | Slynd |
| Agile Therapeutics, INC. | $22.13 | 2021 | |
| Coopersurgical, INC. | $18.79 | 2024 | Paragard T 380a |
| Radius Health, INC. | $18.18 | 2025 | Tymlos |
| Ascend Therapeutics US, LLC | $15.00 | 2020 | |
| Exact Sciences Corporation | $13.60 | 2024 | Cologuard Collection Kit |
| Teleflex LLC | $13.44 | 2022 | |
| Evofem Biosciences, INC. | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.